ACTIVELLA

LOE Approaching

estradiol; norethindrone acetate

Novo Nordisk
NDAORALTABLET
Approved
Apr 2000
Lifecycle
LOE Approaching
Competitive Pressure
30/100

Mechanism of Action

characteristics. Although circulating estrogens exist in a dynamic equilibrium of metabolic interconversions, estradiol is the principal intracellular human estrogen and is substantially more potent than its metabolites, estrone and estriol, at the receptor level. The primary source of estrogen in…

Indications (5)

a woman with a uterus for: Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause Treatment of Moderate to Severe Symptoms of VulvarVaginal Atrophy due to Menopause Limitations of Use :vaginal atrophy due to menopausefirst consider the use of topical vaginal productsOsteoporosis
Company
Novo Nordisk
Novo Nordisk
BAGSVAERD DENMARK, Denmark
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers